Navigation Links
Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
Date:7/15/2008

s to move forward in their research. Today, Ingenuity's solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, and academic research institutions worldwide. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, Australia, and Japan. http://www.ingenuity.com.


'/>"/>
SOURCE Ingenuity Systems
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ingenuitys Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference
2. Ingenuity Systems Delivers Key Milestones in FDA Collaboration to Facilitate Genomic Data Review
3. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
4. Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc.
5. IgeaCare Systems USA, Inc. enters distribution agreement with Jenne Distributors, Inc.
6. Fox Learning Systems Selects Prymaks Discovery-180(TM) Technology Assessment to Guide Search for New LMS
7. Fragmented Los Angeles Hospital Market Provides Health Systems with Little Leverage to Negotiate Higher Reimbursement
8. SouthMed, Inc. and Vocollect Healthcare Systems Announce Reseller Agreement
9. NOTES research activities increase with grants from Olympus medical Systems totaling $1 million
10. Milton Frank Appointed COO of Life Recovery Systems
11. Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...m for Seniors Unlocks Potential, Encourages Growth...ire/ -- Brookdale Senior Living, http:// www....tor of senior living communities in the United Sta...ions 2009. A yearlong life enrichment and dining p...sidents and communities, Celebrations offers theme...
(Date:1/8/2009)...cancer is much more likely to be deadly for women ...ed to explain the phenomenon account for only part...their white and male counterparts, according to re... Cancer . , The results present a stark questio...d stage of the disease upon diagnosis don,t accoun...
(Date:1/8/2009)... Agency will lead public relations ...roducts , Los Angeles, CA...c., has selected GolinHarris as agency of record t...reg; LLC, a wholly owned subsidiary. The agency is...essaging, traditional media outreach and developin...
(Date:1/8/2009)...ional resources for improved patient safety can be...and other features , , HARRISBURG, Pa., Jan. 8 ...t Safety Authority launched its new website and de...h easier navigation and features allowing users to... , The new site www.patientsafetyauthority.org ...
Breaking Medicine News(10 mins):Health News:Senior Living Provider Invites Residents to Dream. Dare. Discover! 2Health News:Senior Living Provider Invites Residents to Dream. Dare. Discover! 3Health News:Why bladder cancer is deadlier for some 2Health News:Why bladder cancer is deadlier for some 3Health News:Why bladder cancer is deadlier for some 4Health News:Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand 2Health News:Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand 3Health News:Pennsylvania Patient Safety Authority Launches New Website and Design With New Tagline 'Analyzing, Educating and Collaborating for Patient Safety' 2
...d to better health and the prevention of some dise...now have now substantial proof to add breast cance...ade who led the research published findings in the... of Epidemiology. She and her team reviewed more ...
...und that meat or milk from clones of adult cattle,... as safe to eat as food from// conventionally bred...mment on three documents regarding the safety of a... proposed risk management plan, and a draft guidan...
...d Health Organization (WHO), is calling for renewe...ent outbreaks in South Korea, Hong Kong, Indonesia...mation yet, but the death of an Indonesian recentl...us that could be transmitted from person to person...
... findings from a study that indicates the superior...RIs) like celexa in combating// depression. Dr. F...ty of Montreal and his colleagues published their ... of the Journal of the American Medical Associatio...
Other Medicine News:Health News:High-fibre Diets can Bust Breast Cancer 2Health News:FDA Finds Animal Cloned Food to Be Safe 2Health News:Are We Prepared for Flu Pandemic? 2Health News:Citalopram, a Boon in Treating Depressed Heart Patients 2
(Date:1/8/2009)...reated at the initial dose in an ongoing Phase Ib ...ecline after three days , , Conference Call Tod...wire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (N...irst cohort of an ongoing Phase Ib clinical trial ...oside polymerase inhibitor. ANA598 was very well-...
(Date:1/7/2009)...everal Products in Development Based On Osteotech,...te Natural BioRegeneration; FDA Filing Anticipated...n. 7 Osteotech, Inc. (...f biologic products for regenerative healing, anno...al trial for its DuraTech(TM) BioRegeneration Matr...
(Date:1/6/2009)....Y., Jan. 6 In recent controlled s...ty of Memphis , scientists found that the patented... first and only proven ingredient to increase leve...asing blood nitrate/nitrate (NOx) in human subject...nables an increase in blood flow to the skeletal m...
(Date:1/6/2009)... France, January 6 , ... Collaboration Until,December 2011 , - Exp...e Antibody,Discovery in Ophthalmology , - ...f Allergan,Sublicenses to a Third Party , ...nounced a reinforcement,of its existing drug disc...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Dental Implants Need More Work Than Root Canals 30236 1Dental Implants Need More Work Than Root Canals 30236 2Epocrates Offers International Market Research Panel 30234 1Epocrates Offers International Market Research Panel 30234 2Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED 1077 30232 1Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED 1077 30232 2Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED 1077 30232 3Radius Raises Additional 2415 Million Increasing Second Private Equity Financing Round to 2482 5 Million 3463 1Radius Raises Additional 2415 Million Increasing Second Private Equity Financing Round to 2482 5 Million 3463 2
...l and Regulatory Development of Oral,Anti-Inflamma...wire-FirstCall/ -- Celgene,Corporation announced i...l anti-inflammatory candidates across a broad rang... an oral TNF,antagonist and anti-inflammatory agen...ellent side effect profile in a placebo,controlled...
...--May 22, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israe...ay data from its Phase I trial of BL-1020, the fir...for the treatment of,schizophrenia. The trial demo...demonstrated biochemical evidence of dopamine,bloc...esented the,data in a poster (Abstract 235 XX) at ...
Other Medicine Technology:Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 2Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 3Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 4BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4
...ransfer System is a patent-pending disposable, med...s simpler for the physician and their staff, and t...LipiVage™ improves upon traditional fat tran...uge, decant or expose fat cells to unnecessary han...
...Zyplast® injectable collagen implants have set...cial lines, wrinkles and scars and in providing li...ns natural collagen, require minimal procedure tim... one million people worldwide have been treated wi...
SCULPTRA™ is an injectable implant that contains microparticles of poly-L-lactic acid, a biocompatible, biodegradable, synthetic polymer from the alpha-hydroxy-acid family. SCULPTRA is reconsti
Revitol Cellulite Cream is a revolutionary scientific breakthrough for controlling unsightly cellulite and eliminating inches. Revitol Cellulite Removal Cream permits you to spot reduce in those impo
Medicine Products: